Powell F C, Rogers R S, Dickson E R
J Am Acad Dermatol. 1983 Oct;9(4):540-5. doi: 10.1016/s0190-9622(83)70166-0.
Lichen planus and primary biliary cirrhosis were seen in twenty-four patients. In seventeen patients, the cutaneous eruption followed the administration of D-penicillamine. In seven patients, lichen planus developed unrelated to therapy. Three of the latter group of patients were treated with D-penicillamine and had subsequent relapse or exacerbation of their preexisting lichen planus. The presence of lichen planus in patients with primary biliary cirrhosis and the propensity to develop this type of eruption while on D-penicillamine therapy are consistent with a graft-versus-host pathogenesis of primary biliary cirrhosis. Preexisting lichen planus should be regarded as a relative contraindication to the use of D-penicillamine in patients with primary biliary cirrhosis.
24例患者出现扁平苔藓和原发性胆汁性肝硬化。17例患者在服用D-青霉胺后出现皮肤疹。7例患者的扁平苔藓与治疗无关。后一组患者中有3例接受了D-青霉胺治疗,随后原有扁平苔藓复发或加重。原发性胆汁性肝硬化患者中扁平苔藓的存在以及在D-青霉胺治疗期间出现这种皮疹的倾向与原发性胆汁性肝硬化的移植物抗宿主发病机制一致。对于原发性胆汁性肝硬化患者,原有扁平苔藓应被视为使用D-青霉胺的相对禁忌证。